APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,934,206 | -14.3% | 1,023,507 | +105.2% | 0.12% | -22.9% |
| Q2 2023 | $45,432,481 | -7.3% | 498,710 | -32.9% | 0.16% | -9.8% |
| Q1 2023 | $49,024,506 | +130176.9% | 743,246 | +2.1% | 0.17% | +27.9% |
| Q4 2022 | $37,631 | -100.0% | 727,729 | -40.6% | 0.14% | -57.6% |
| Q3 2022 | $83,690,000 | +109.5% | 1,225,336 | +38.7% | 0.32% | +116.9% |
| Q2 2022 | $39,949,000 | +53.3% | 883,438 | +72.2% | 0.15% | +105.6% |
| Q1 2022 | $26,067,000 | +719.5% | 513,027 | +662.5% | 0.07% | +700.0% |
| Q4 2021 | $3,181,000 | -78.7% | 67,282 | -71.5% | 0.01% | -82.4% |
| Q2 2021 | $14,901,000 | +2904.2% | 235,775 | +1334.8% | 0.05% | +1600.0% |
| Q3 2020 | $496,000 | -15.4% | 16,433 | -32.4% | 0.00% | -25.0% |
| Q3 2019 | $586,000 | -90.3% | 24,312 | -92.1% | 0.00% | -93.0% |
| Q1 2019 | $6,025,000 | – | 308,992 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |